FOXP3 and synovial sarcoma: Since the original findings by Berger and colleagues that CTCL involved malignant proliferation of Treg cells, several studies have investigated whether or not malignant cells displayed a FOXP3+ (refs. 19,24–29) phenotype in peripheral blood of SS patients.